Parkinson's Disease Trial, By Invitation NCT06597071 Sponsor: NeuraLight Condition: Parkinson's Disease
Back to Parkinsons Disease

Parkinson's Disease Trial, By Invitation

NCT06597071
By Invitation Not Applicable

voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice

Who may and may not be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who may be able to join

  • Men and women between 40 and 80 years of age
  • People who were diagnosed with their condition less than 5 years ago
  • People with normal vision or vision that is fully corrected (for example, with glasses or contact lenses)
  • People who score 20 or higher on a standard memory and thinking test called the MoCA
  • People who are able to follow instructions during the study
  • People who are willing and able to sign a consent form agreeing to take part
  • For the Parkinson's disease group specifically: people between 50 and 80 years of age whose disease is at an early to moderate stage (rated 1 to 3 on a standard scale used by doctors)
  • For the PSP group specifically: people who have been diagnosed with PSP according to the recognised 2017 diagnostic guidelines (confirm with trial site)
  • For the MSA group specifically: people who have been diagnosed with MSA according to the recognised 2022 diagnostic guidelines (confirm with trial site)

Who may not be able to join

Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.

  • No specific exclusion criteria have been listed for this trial (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
By Invitation
Phase
Not Applicable
Sponsor
NeuraLight
Registry
ClinicalTrials.gov
Start date
10 September 2024
Est. completion
1 October 2025

This date has passed while the registry still lists the trial as open to participants. Sponsors often update a trial's status without revising its projected end date, so it may well still be recruiting — but the record is out of date in at least one respect. Check with the study contact before relying on either.

Where this trial is recruiting

🇪🇸 Spain

Primary endpoints

Change of saccadic latency between subgroups; Change of antisaccadic error rate between subgroups; Change of saccadic latency over time as evaluated during visits; Change of antisaccadic error rate over time as evaluated during visits; Correlation between MDS-UPDRS score and its parts with saccadic latency; Correlation between UMSARS score and its parts with saccadic latency; Correlation between PSP-CDS and its parts with saccadic latency

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov